Interview: Paweł Mazur – East Area Director, Accord Healthcare, Poland
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Address: ul. Józefińska 2, 30-529 Kraków,Poland
Tel: +48 12 421 18 51
Our company has been operating on the Polish market since 2001. As early as in 2003, we registered our first medication: Doxycyclinum 100 mg – an antibiotic from the group of tetracyclines.
From the very beginning of its existence, the Company was focused on promotion of its own generic products on the market and on strict cooperation with entities interested in promoting their own medications. We have entrusted the process of manufacturing our medications to the best European pharmaceutical companies meeting the highest standards and norms concerning the production process. Since March 2006, United Pharma Sp. z o.o. from Kraków has been one of the partners strictly cooperating with our company. Until the merger in 2008, Farma-Projekt promoted for that company Uprox 0,4 mg (Tamsulosini hydrohloridum) and Xentic (Zolpidemi tartras) 10 mg, as well as a well-known dietary supplement Lactiv Up.
During the several years of its existence and nearly three years from commencement of active promotion of medications, Farma-Projekt generates profits and constantly improves its position in the ranking of Polish pharmaceutical companies.
As early as in June 2004, we could boast of creating our first own group of Medical Representatives composed of 15 persons. Currently the team of our Medical Representatives is composed of 120 people!
Dietary supplements
Rx Medications:
Doxycyclinum Farma-Projekt Doxycyclinum
Gastroenterology
Contracid Pantoprazolum
Cardiology
Carder Clopidogrelum
Nebinad Nebivololum
Ramve Ramiprilum
Sarve Losartanum kalicum
Ximve Simvastatinum
Neurology
Vertix Betahistini dihydrochloridum
Xentic Zolpidemi tartras
Urology
Finxta Finasteride
Uprox Tamsulosini hydrochloridum
As east area director for the vast CEE market, Pawel Mazur explains how Accord Healthcare has gone from strength to strength in Poland, with the intention of becoming a top…
Krzysztof Popławski, general manager of Baxter Poland, discusses the Baxter Education Center, the largest educational program for a European affiliate, and its role in raising the awareness within the Polish…
Hubert Niemyjski, country manager of Coloplast Poland and the Baltics, highlights the large differences between the market landscape of the company’s three pillars; ostomy, wound and continence care. Additionally, he…
Olympus is internationally well-regarded as being a quality camera provider and continues to provide developed countries across the globe with high-tech medical devices from endoscopes to imagery solutions. Tomasz Mrzygłód,…
Paweł Migdalski, CEO at Siemens Healthineers Poland, discusses the innovations they are bringing to the market and how they are building on the success of the Siemens Healthineers Academy. Furthermore,…
Tomasz Dzitko, founder and CEO of Delfarma, Poland’s leading parallel importer, gives an overview of the sector in Poland and its impact on the healthcare ecosystem, as well as the…
Piotr Steczniewski, president of Profarm PS – a successful wholesale family business – since 2012, shares how the company has managed to thrive over the years through constant adaptation to…
Łukasz Korybalski, regional manager of Becton Dickinson (BD) Central Eastern Europe, discusses the rising significance of the region as the company continues to grow and the strategic importance of Poland,…
Marzena Kulis, managing director of Johnson & Johnson Medical Devices CEE, highlights the importance of the region and Poland within J&J Medical Devices, and the impact of increasing healthcare expenditures…
Despite the global R&D excitement around oncology, cardiovascular death still remains the world’s largest killer, and according to OECD data, accounts for roughly a third of all mortalities. This trend…
Cezary Kilczewski, president and founder of Medicofarma, a Polish CMO, discusses the company’s recent upgrades to double production capacity and the move into R&D operations as well as the dynamics…
Andrzej Schonert, CEO of Synoptis Industrial, discusses the intricacies of the Polish market and the requirement to move into niche areas, mainly in Rx, to concentrate their pharmaceutical offering to…
See our Cookie Privacy Policy Here